BR9611815A - Tablete de mascar com ação efervescente - Google Patents

Tablete de mascar com ação efervescente

Info

Publication number
BR9611815A
BR9611815A BR9611815-6A BR9611815A BR9611815A BR 9611815 A BR9611815 A BR 9611815A BR 9611815 A BR9611815 A BR 9611815A BR 9611815 A BR9611815 A BR 9611815A
Authority
BR
Brazil
Prior art keywords
tablet
free
active substances
effervescent agent
chewing tablet
Prior art date
Application number
BR9611815-6A
Other languages
English (en)
Inventor
Irmgard Gergely
Thomas Gergely
Original Assignee
Gergely Gerhard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gergely Gerhard filed Critical Gergely Gerhard
Publication of BR9611815A publication Critical patent/BR9611815A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0007—Effervescent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Abstract

Patente de Invenção: <B>''TABLETE DE MASCAR COM AçãO EFERVESCENTE''<D>. Tablete de mascar contém uma pequena quantidade de agente efervescente (que fornece uma sensação picante prazerosa na boca), substâncias ativas e cargas, em quantidades escolhidas de tal modo que o tablete contudo dissolver-se-á - com a exceção, quando muito, de quaisquer substâncias ativas insolúveis ou fracamente solúveis - em 100 ml de água na temperatura de 15 até 20°C em menos do que 120, de preferência em no máximo 90 segundos. Isto é conseguido em virtude do fato de que as partículas de ácido e/ou de carbonato do agente efervescente estão revestidas com um hidrocolóide de preferência fácil ou rapidamente solúvel, e/ou a substância ativa está livre de agentes de encapsulação, ou a mistura de tablete está livre de agentes lubrificantes. O peso do tablete é de 600 a 1500mg, de preferência de apenas 700 a 1200 mg.
BR9611815-6A 1995-07-31 1996-07-18 Tablete de mascar com ação efervescente BR9611815A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH223095 1995-07-31
PCT/EP1996/003165 WO1997004754A1 (de) 1995-07-31 1996-07-18 Kautablette mit brausewirkung

Publications (1)

Publication Number Publication Date
BR9611815A true BR9611815A (pt) 1999-10-13

Family

ID=4228915

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9611815-6A BR9611815A (pt) 1995-07-31 1996-07-18 Tablete de mascar com ação efervescente

Country Status (11)

Country Link
US (1) US5869095A (pt)
EP (1) EP0804171B1 (pt)
JP (1) JPH11509854A (pt)
CN (1) CN1192137A (pt)
AR (1) AR003014A1 (pt)
AT (1) ATE188376T1 (pt)
AU (1) AU6734096A (pt)
BR (1) BR9611815A (pt)
DE (1) DE59604114D1 (pt)
ES (1) ES2142601T3 (pt)
WO (1) WO1997004754A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5804165A (en) * 1996-07-24 1998-09-08 Arnold; Michael J. Antiplaque oral composition
KR100775154B1 (ko) * 1997-12-19 2007-11-12 스미스클라인 비참 코포레이션 바이트-분산성 정제의 제조 방법
US6589555B2 (en) 1999-12-29 2003-07-08 Mahendra Pandya Effervescent vitaceutical compositions and related methods
US6544557B2 (en) 2001-01-09 2003-04-08 Pan Pharmaceutical Limited Effervescent tablet compositions
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
US7488496B2 (en) 2002-03-06 2009-02-10 Christer Rosen Effervescent compositions comprising bisphosphonates and methods related thereto
NZ574520A (en) 2002-11-27 2011-02-25 Dmi Biosciences Inc Use of casein which is at least 10% dephosphorylated for the treatment of diseases and conditions mediated by increased phosphorylation
US20040223921A1 (en) * 2003-05-07 2004-11-11 Rau Allen H. Oral care tablet
CN1886126A (zh) * 2003-09-25 2006-12-27 Dmi生物科学公司 利用n－酰基－l－天冬氨酸的方法和产品
EP1750677B1 (en) * 2004-05-28 2017-02-01 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US8216610B2 (en) * 2004-05-28 2012-07-10 Imaginot Pty Ltd. Oral paracetamol formulations
US20060045855A1 (en) * 2004-09-02 2006-03-02 Sasson J A Oral composition for reducing plaque and microbial infections and whitening teeth
BRPI0610780A2 (pt) * 2005-04-22 2016-09-06 Teva Pharma formulação farmacéutica em tablete desintegrante, e, métodos para tratar um paciente em necessidade de tratamento com olanzapina, e para produzir a formulação farmacêutica em tablete
CA2629904C (en) * 2005-11-28 2018-07-10 Imaginot Pty Ltd. Oral therapeutic compound delivery system
US20090269393A1 (en) * 2006-06-12 2009-10-29 Jubliant Organosys Limited Chewable Bilayer Tablet Formulation
CN101829333B (zh) * 2010-05-27 2012-01-25 上海华茂药业有限公司 一种口腔崩解片的多功能辅料及其制备方法
EP2441436A1 (de) * 2010-10-13 2012-04-18 Fresenius Medical Care Deutschland GmbH Phosphatbinderformulierung zur einfachen Einnahme
US20140371174A1 (en) 2013-06-12 2014-12-18 The Procter & Gamble Company Effervescent Dosage Form
CA2876062C (en) 2012-06-12 2017-09-12 The Procter & Gamble Company Effervescent dosage form
FR3003135B1 (fr) * 2013-03-12 2020-10-02 Syral Belgium Nv Procede pour ameliorer les proprietes organoleptiques de gomme a macher sans sucres a base de sorbitol
LT3174521T (lt) 2014-07-31 2018-12-27 Pharmathen S.A. Vaikams skirta kramtoma tabletė, turinti antivirusinio agento, ir jos gavimo būdas
JP2020103185A (ja) * 2018-12-27 2020-07-09 花王株式会社 密封容器入り発泡性経口錠剤
CN114041549B (zh) * 2021-11-29 2024-02-20 青岛博恩高科生物技术有限公司 一种电解质泡腾粉的制备方法及电解质泡腾粉

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby
CH677606A5 (pt) * 1988-07-12 1991-06-14 Aesculapius Pharma Sa
CA2023493C (en) * 1989-08-31 2000-01-04 Masami Moroi Composition for foaming preparation
ES2097155T3 (es) * 1989-10-02 1997-04-01 Cima Labs Inc Forma de dosificacion efervescente y metodo de administracion.
US5064656A (en) * 1989-11-14 1991-11-12 Dr. Gergely & Co. Uncoated pharmaceutical reaction tablet
EP0525388B1 (de) * 1991-07-01 1995-09-20 Gerhard Dr. Gergely Lutsch- oder Kautablette

Also Published As

Publication number Publication date
CN1192137A (zh) 1998-09-02
ES2142601T3 (es) 2000-04-16
JPH11509854A (ja) 1999-08-31
EP0804171A1 (de) 1997-11-05
AU6734096A (en) 1997-02-26
AR003014A1 (es) 1998-05-27
US5869095A (en) 1999-02-09
DE59604114D1 (de) 2000-02-10
EP0804171B1 (de) 2000-01-05
ATE188376T1 (de) 2000-01-15
WO1997004754A1 (de) 1997-02-13

Similar Documents

Publication Publication Date Title
BR9611815A (pt) Tablete de mascar com ação efervescente
CA2149362A1 (en) Pharmaceutical composition based on guar gum coated with simethicone, inassociation with a neutralizing antacid
AU3731699A (en) Orally disintegrable tablets
BR9802487A (pt) Composicões de simeticona/fosfato de cálcio anídrico.
BR9810658A (pt) Composições farmacêuticas contendo hemissulfato de eletriptano e cafeìna.
BR9808944A (pt) Confeitos com centro recheado
BR0207930A (pt) Composições farmacêuticas lìquidas com sabor mascarado
UA42061C2 (uk) Фармацевтична композиція для перорального введення, що містить інгібітори протонного насоса
TNSN99173A1 (fr) Livraison d&#39;agent actif sous forme de poudre seche
KR900013952A (ko) 경구투여용 이부프로펜 조성물
BR0014441A (pt) Composições que apresentam estabilidade aperfeiçoada
FI943315A (fi) Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä
MY100194A (en) Liquid shampoo composition
BRPI9914977B8 (pt) composição multiparticulada de liberação modificada
BR9808947A (pt) Composições calmantes de garganta
KR950703327A (ko) 씹을 수 있는 라니티딘 정제(Ranitidine Chewable Tablets)
SE8702940D0 (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
TR200003688T1 (tr) Glutation&#39;un absorbsıyonu&#39;nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon
NZ337418A (en) Paracetamol composition with improved rate of absorption
HUP0402492A2 (hu) 5HT4 részleges agonistát tartalmazó gyógyszerkészítmények
CA2136404A1 (fr) Composition solide mucoadhesive, therapeutique ou hygienique, pour administration par application sur la muqueuse buccale ou nasale
KR940003547A (ko) 제산제
BR9809310A (pt) Composição lìquida aquosa derramável, composições farmacêuticas e processos para o tratamento da esofagite de refluxo, gastrite, dispepsia ou ulceração péptica, e para formar um revestimento protetor sobre o tecido da mucosa gastrintestinal, composição farmacêutica em forma de dosagem unitária sólida.
NZ505821A (en) Pharmaceutical compositions of uridine triphosphate
HUP0202744A2 (hu) Orális, rivasztigmint tartalmazó szabályozott hatóanyag-leadású készítmények

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B11D Dismissal acc. art. 38, par 2 of ipl - failure to pay fee after grant in time